查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1610332

quinidine sulfate市場：按給藥途徑、應用和最終用戶分類 - 2025-2030 年全球預測

Quinidine Sulfate Market by Route of Administration (Intravenous, Oral), Application (Arrhythmias, Malaria), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

quinidine sulfate市場2023年估值為127.9億美元，預計2024年將達到137.4億美元，複合年成長率為6.30%，到2030年將達到196.3億美元。

quinidine sulfate是一種廣泛用作抗心律不整藥物，用於治療某些類型的心律不整的藥物。quinidine sulfate廣泛用作治療心律不整的抗心律不整藥物，其用途主要用於循環系統醫學，對於維持心臟的正常節律和預防與心律不整相關的併發症具有重要意義。對quinidine sulfate的需求源自於心血管疾病盛行率的增加和有效心律不整管理的需要。除了循環系統之外，其最終用途還擴展到包括醫院和專科診所在內的醫療機構，這些機構的管理是在專家的監督下進行的。推動市場成長的主要因素是心血管疾病盛行率的上升、醫療基礎設施的進步以及人們對心臟健康的認知不斷提高。此外，藥物配方和藥物傳輸方法的技術進步正在推動需求，並為市場參與者加強研發工作提供充足的機會。主要市場參與者可以探索創新的藥物傳遞機制，例如緩釋性，以提高治療效果和依從性。

主要市場統計
基準年[2023] 127.9億美元
預測年份 [2024] 137.4億美元
預測年份 [2030] 196.3億美元
複合年成長率（%） 6.30%

然而，市場面臨一些挑戰。特別是，嚴格的法律規範、quinidine sulfate的潛在副作用以及新替代品的可用性可能會限制其採用。監管障礙和嚴格的臨床試驗要求可以延長新產品的上市時間。此外，副作用和禁忌症可能會限制奎尼丁的使用，持續的患者監測至關重要。為了克服這些限制並抓住成長機會，公司應該投資於全面的臨床研究和開發，以加強奎尼丁的安全性並探索更廣泛的治療領域的新應用。在創新方面，有潛力利用生物技術來改進配方和精準醫學，以改善針對患者的治療模式。對市場格局的回顧揭示了競爭格局，各個相關人員強調增強產品供應和策略聯盟以開拓的市場。透過專注於醫療保健支出不斷增加和醫療保健政策不斷發展的新興市場，公司可以最大限度地提高未來的成長前景並提高其市場佔有率。

市場動態：快速發展的quinidine sulfate市場的關鍵市場洞察

quinidine sulfate市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 心律不整和瘧疾等疾病的發生率增加
    • 政府積極努力意識提升對quinidine sulfate補充品的認知
    • 推廣奎尼丁靜脈注射防治重症惡性瘧及高寄生蟲血症
  • 市場限制因素
    • 抗殺蟲劑載體的可用性問題
  • 市場機會
    • quinidine sulfate核准加大研發投入
    • quinidine sulfate藥物研究進展
  • 市場挑戰
    • 增加使用抗心律不整藥物帶來的健康風險

波特五力策略工具引領quinidine sulfate市場

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解quinidine sulfate市場的外部影響

外部宏觀環境因素在塑造quinidine sulfate市場的表現動態中起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解quinidine sulfate市場的競爭格局

對quinidine sulfate市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣硫酸quinidine sulfate市場供應商的績效評估

FPNV 定位矩陣是評估quinidine sulfate市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了quinidine sulfate市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，quinidine sulfate市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心律不整和瘧疾等疾病的發生率增加
      • 政府首選舉措，以提高大眾對quinidine sulfate補充品的認知
      • 推廣靜脈注射奎尼丁防治重症惡性瘧和高寄生蟲血症
    • 抑制因素
      • 抗殺蟲劑載體的可用性問題
    • 機會
      • quinidine sulfate加大藥品核准與研發投入
      • quinidine sulfate藥物研究進展
    • 任務
      • 增加使用抗心律不整藥物帶來的健康風險
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章quinidine sulfate市場：依給藥途徑

  • 靜脈
  • 口服

第7章quinidine sulfate市場：依應用分類

  • 心律不整
  • 瘧疾

第8章quinidine sulfate市場：依最終用戶分類

  • 成人
  • 小兒科

第9章 北美、南美quinidine sulfate市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太地區quinidine sulfate市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲quinidine sulfate市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • Apotex Corporation
  • BUCHLER GmbH
  • ChemPoint
  • Inga Laboratories P. Ltd.
  • Merck KGaA
  • Novartis AG
  • Prism Industries Private Ltd.
  • PT Sinkona Indonesia lestar
  • Vital Laboratories Pvt. Ltd.
  • VIVAN Life Sciences Pvt. Limited
Product Code: MRR-62667ADFACBE

The Quinidine Sulfate Market was valued at USD 12.79 billion in 2023, expected to reach USD 13.74 billion in 2024, and is projected to grow at a CAGR of 6.30%, to USD 19.63 billion by 2030.

Quinidine sulfate is a medication prominently used as an antiarrhythmic agent to treat certain types of irregular heartbeats. Its market encompasses the pharmaceutical sector, focusing largely on cardiology where its application is critical in maintaining normal heart rhythms and preventing complications associated with arrhythmias. The necessity for quinidine sulfate stems from the increasing prevalence of cardiovascular diseases and the need for effective arrhythmia management. Besides cardiology, its end-use scope extends to medical facilities, including hospitals and specialty clinics where it is administered under professional supervision. Market growth is primarily driven by the rising incidence of cardiovascular disorders, advancements in healthcare infrastructure, and increasing awareness about cardiac health. Further, technological strides in drug formulation and delivery methods foster demand, providing ample opportunities for market players to intensify R&D efforts. Key market players can explore innovative drug delivery mechanisms, such as sustained-release formulations, to enhance therapeutic efficacy and compliance.

KEY MARKET STATISTICS
Base Year [2023] USD 12.79 billion
Estimated Year [2024] USD 13.74 billion
Forecast Year [2030] USD 19.63 billion
CAGR (%) 6.30%

However, the market faces several challenging factors, notably stringent regulatory frameworks, potential side effects of quinidine sulfate, and the availability of newer alternatives possibly limiting its adoption. Regulatory hurdles and rigorous clinical trial requirements can extend time-to-market for new developments. Additionally, adverse reactions and contraindications might restrict quinidine's use, making the need for continuous monitoring of patients critical. To overcome these limitations and capture growth opportunities, companies should invest in comprehensive clinical research and development to enhance quinidine's safety profile and explore novel applications in broader therapeutic areas. In terms of innovation, there's potential in leveraging biotechnology to refine drug formulations or improve patient-specific treatment paradigms using precision medicine. Insights into market nature reveal a competitive landscape with various stakeholders emphasizing enhanced product offerings and strategic alliances to penetrate untapped markets. By focusing on emerging markets with rising healthcare expenditures and evolving healthcare policies, organizations can maximize future growth prospects and fortify their market presence.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Quinidine Sulfate Market

The Quinidine Sulfate Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in incidence of arrhythmia and other diseases, such as malaria
    • Favorable government initiatives for increasing awareness among people about quinidine sulfate supplements
    • Prevalence for intravenous quinidine to control severe P. Falciparum and hyperparasitemia
  • Market Restraints
    • Issues regarding availability of insecticide-resistant vectors
  • Market Opportunities
    • Increasing drug approvals and investments in R&D of quinidine sulfate
    • Advancements in quinidine sulfate drugs
  • Market Challenges
    • Health risks due to the increased use of antiarrhythmic drug

Porter's Five Forces: A Strategic Tool for Navigating the Quinidine Sulfate Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Quinidine Sulfate Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Quinidine Sulfate Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Quinidine Sulfate Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Quinidine Sulfate Market

A detailed market share analysis in the Quinidine Sulfate Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Quinidine Sulfate Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Quinidine Sulfate Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Quinidine Sulfate Market

A strategic analysis of the Quinidine Sulfate Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Quinidine Sulfate Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Apotex Corporation, BUCHLER GmbH, ChemPoint, Inga Laboratories P. Ltd., Merck KGaA, Novartis AG, Prism Industries Private Ltd., PT Sinkona Indonesia lestar, Vital Laboratories Pvt. Ltd., and VIVAN Life Sciences Pvt. Limited.

Market Segmentation & Coverage

This research report categorizes the Quinidine Sulfate Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Route of Administration, market is studied across Intravenous and Oral.
  • Based on Application, market is studied across Arrhythmias and Malaria.
  • Based on End-User, market is studied across Adults and Pediatrics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in incidence of arrhythmia and other diseases, such as malaria
      • 5.1.1.2. Favorable government initiatives for increasing awareness among people about quinidine sulfate supplements
      • 5.1.1.3. Prevalence for intravenous quinidine to control severe P. Falciparum and hyperparasitemia
    • 5.1.2. Restraints
      • 5.1.2.1. Issues regarding availability of insecticide-resistant vectors
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing drug approvals and investments in R&D of quinidine sulfate
      • 5.1.3.2. Advancements in quinidine sulfate drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Health risks due to the increased use of antiarrhythmic drug
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Quinidine Sulfate Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Intravenous
  • 6.3. Oral

7. Quinidine Sulfate Market, by Application

  • 7.1. Introduction
  • 7.2. Arrhythmias
  • 7.3. Malaria

8. Quinidine Sulfate Market, by End-User

  • 8.1. Introduction
  • 8.2. Adults
  • 8.3. Pediatrics

9. Americas Quinidine Sulfate Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Quinidine Sulfate Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Quinidine Sulfate Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Apotex Corporation
  • 3. BUCHLER GmbH
  • 4. ChemPoint
  • 5. Inga Laboratories P. Ltd.
  • 6. Merck KGaA
  • 7. Novartis AG
  • 8. Prism Industries Private Ltd.
  • 9. PT Sinkona Indonesia lestar
  • 10. Vital Laboratories Pvt. Ltd.
  • 11. VIVAN Life Sciences Pvt. Limited

LIST OF FIGURES

  • FIGURE 1. QUINIDINE SULFATE MARKET RESEARCH PROCESS
  • FIGURE 2. QUINIDINE SULFATE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL QUINIDINE SULFATE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. QUINIDINE SULFATE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. QUINIDINE SULFATE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. QUINIDINE SULFATE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL QUINIDINE SULFATE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. QUINIDINE SULFATE MARKET DYNAMICS
  • TABLE 7. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ARRHYTHMIAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY MALARIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL QUINIDINE SULFATE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES QUINIDINE SULFATE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA QUINIDINE SULFATE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM QUINIDINE SULFATE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM QUINIDINE SULFATE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM QUINIDINE SULFATE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. QUINIDINE SULFATE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. QUINIDINE SULFATE MARKET, FPNV POSITIONING MATRIX, 2023